Nanotherapeutic technology could safely, effectively convert bad fat to good fat, treat obesity
24 mai 2017 10h00 HE
|
Purdue Research Foundation
West Lafayette, IN, May 24, 2017 (GLOBE NEWSWIRE) -- A Purdue-based startup is developing a disruptive nanotherapeutic platform that could induce conversion of bad fat to good fat in an effort to...
American Health Council Names Jaime Steinsapir, M.D., PhD, FACP, FACE to Physician Board
23 mai 2017 14h28 HE
|
American Health Council
NEW YORK, May 23, 2017 (GLOBE NEWSWIRE) -- Dr. Jaime Steinsapir, Endocrinologist at Palm Beach Diabetes and Endocrine Specialists, PA has been selected to join the Physician Board at the American...
Plandaí Biotechnology's Upcoming Clinical Trial Could Strengthen Case for Phytofare in Treatment of Diabetes
18 mai 2017 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 18, 2017) - Plandaí Biotechnology (OTCQB: PLPL) announced that it will conduct a human clinical trial to study the effectiveness of using its highly bioavailable...
Xeris Pharmaceuticals Announces Closing of $30 Million Financing
17 mai 2017 19h00 HE
|
Xeris Pharmaceuticals, Inc.
CHICAGO, IL and AUSTIN, TX, May 17, 2017 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on the development and commercialization of novel formulations...
Solera Health Appoints Danielle Turnipseed Vice President of Government Affairs and Policy
17 mai 2017 10h27 HE
|
Solera Health
WASHINGTON, May 17, 2017 (GLOBE NEWSWIRE) -- Solera Health, a preventive care benefits manager, announced today the appointment of Danielle P. Turnipseed, JD, MPP, M.H.S.A., as vice president...
CohBar, Inc. Announces First Quarter 2017 Financial Results
15 mai 2017 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., May 15, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSX-V:COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs)...
Plandai Biotechnology Sets Aggressive Agenda for 2017
19 avr. 2017 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - April 19, 2017) - Plandaí Biotechnology (OTCQB: PLPL) recently presented investors with its outlook for 2017 and a number of milestones that the company plans to...
WellDoc® Enters Joint Commercial Partnership Agreement with Samsung for BlueStar® C, New Consumer-Focused Diabetes Health Application
19 avr. 2017 09h00 HE
|
WellDoc Inc.
COLUMBIA, Md., April 19, 2017 (GLOBE NEWSWIRE) -- Digital health technology leader, WellDoc, announced today it has entered a joint commercial partnership agreement with multinational electronics...
IFC, WellDoc, and Max Healthcare Launch an Innovative App in India to Improve Diabetes Care
23 mars 2017 17h00 HE
|
WellDoc Inc.
WASHINGTON and COLUMBIA, Md. and NEW DELHI, India, March 23, 2017 (GLOBE NEWSWIRE) -- IFC, a member of the World Bank Group; WellDoc, a US-based digital health startup; and Max Healthcare, a leading...
Helmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes
16 mars 2017 09h33 HE
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, NY and BEVERLY, MA, March 16, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust and Akston Biosciences Corporation today announced a partnership to advance...